Kowa Pharms Company Profile
What is the competitive landscape for KOWA PHARMS
KOWA PHARMS has one approved drug.
There are seven US patents protecting KOWA PHARMS drugs.
Summary for Kowa Pharms
| US Patents: | 7 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Kowa Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kowa Pharms | SEGLENTIS | celecoxib; tramadol hydrochloride | TABLET;ORAL | 213426-001 | Oct 15, 2021 | DISCN | Yes | No | 8,598,152 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Kowa Pharms | SEGLENTIS | celecoxib; tramadol hydrochloride | TABLET;ORAL | 213426-001 | Oct 15, 2021 | DISCN | Yes | No | 11,478,488 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Kowa Pharms | SEGLENTIS | celecoxib; tramadol hydrochloride | TABLET;ORAL | 213426-001 | Oct 15, 2021 | DISCN | Yes | No | 9,012,440 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Kowa Pharms | SEGLENTIS | celecoxib; tramadol hydrochloride | TABLET;ORAL | 213426-001 | Oct 15, 2021 | DISCN | Yes | No | 10,548,909 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Kowa Pharms | SEGLENTIS | celecoxib; tramadol hydrochloride | TABLET;ORAL | 213426-001 | Oct 15, 2021 | DISCN | Yes | No | 10,245,276 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Kowa Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Mexico | 2011003612 | ⤷ Start Trial |
| Israel | 222731 | ⤷ Start Trial |
| Australia | 2011260608 | ⤷ Start Trial |
| Ecuador | SP12011734 | ⤷ Start Trial |
| China | 104844513 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Kowa Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2488169 | C202330042 | Spain | ⤷ Start Trial | PRODUCT NAME: COCRISTAL DE TRAMADOL, OPCIONALMENTE EN FORMA DE UNA SAL FISIOLOGICAMENTE ACEPTABLE, Y CELECOXIB; NATIONAL AUTHORISATION NUMBER: 89051; DATE OF AUTHORISATION: 20230925; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): 89051; DATE OF FIRST AUTHORISATION IN EEA: 20230925 |
| 0731795 | 10075033 | Germany | ⤷ Start Trial | PRODUCT NAME: CELECOXIB; NAT. REGISTRATION NO/DATE: 48802.00.00 20000518; FIRST REGISTRATION: SE 14838 19991203 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
